Cases Of Covid-19 Are On The Decline

Cases-Of-Covid-19-Are-On-The-Decline-1

After weeks of alarming Covid-19 outbreaks throughout the United States, infection rates have finally begun to decrease. Still, doctors believe more work has to be done first before tide can be reversed, particularly since the number of cases among youngsters continues to be particularly high.

The Johns Hopkins University Center for Infection Control and Prevention reports that about 105,054 individuals acquire new Covid-19 infections on a daily basis on average.

Cases Of Covid-19 Are On The Decline

That figure is about 12,000 lower than the average from the previous week, and experts are debating whether the decrease represents a natural ebb of cases or even the beginning of the end of high case numbers.

According to Dr. Megan Ranney, Associate Dean of Strategy and Development for the Department of Public Health at Brown University, “Whether this is the end of this surge or not is entirely up to us.”

Cases Of Covid-19 Are On The Decline

According to her, increased vaccination rates, the use of face masks inside in outbreak-prone regions, and the vaccination of youngsters are required. Children under the age of 18 make up 22 percent of the population of the United States. Still, they account for 27 percent of all cases in the country, according to statistics released Monday by the Academy Of pediatrics. While the severity and fatality of such instances are less probable, children may have long-term effects as a consequence of their illness.

The overwhelming majority of the people in the United States will need to be vaccinated in order to prevent the spread of the disease. Still, according to statistics from US Centers for Disease Control and Prevention, just 56 percent of the population is completely vaccinated. The Dean of the Department of Medical Sciences at Baylor College of Medicine, Dr. Peter Hotez, said that he is worried about the remainder of the year. The winter months bring with them circumstances that assist in transmitting the disease, and the United States is still under-vaccinated, according to the expert.

It is only for children as young as 12 years old that vaccines are available, which doctors believe in providing the greatest protection against the virus. Health authorities, on the other hand, are hopeful that this will soon change. In a statement issued Friday, the US FDA said that its vaccine advisors would meet on October 26 to review Pfizer’s vaccination study results among children aged 5 to 11. There are still a few procedures to be completed before the vaccine may be approved. In order to vote on a vaccination recommendation, the FDA vaccine advisors would have to make one first.

The Centers for Disease Control and Prevention (CDC) would then have to provide its approval before youngsters between the ages of 5 and 11 could begin receiving vaccinations. Furthermore, if a vaccine is made accessible to younger children, it’d be up to the parents to determine whether or not to administer it, which may prove to be a barrier.